U.S. patent office appeals Glaxo loss
WASHINGTON, May 7 (Reuters) - The U.S. Patent and Trademark Office said on Tuesday it would appeal a court decision that threw out agency rules aimed at limiting the size of patent applications and reducing a backlog of patent applications.
Judge James Cacheris of the U.S. District Court for the Eastern District of Virginia tossed out the rules on April 1, saying they exceeded the patent office's rulemaking authority.
The ruling was a victory for Europe's biggest drugmaker, GlaxoSmithKline PLC (GSK.L), which had challenged the rules, and other companies with large patent portfolios.
The appeal will be filed with the U.S. Court of Appeals for the Federal Circuit, which hears patent appeals. (Reporting by Diane Bartz)
© Thomson Reuters 2009 All rights reserved
Green Shoots / Brown Weeds
Jobless claims drop steeply
The number of U.S. workers filing new claims for jobless benefits fell sharply last week, although the data was distorted by an unusual pattern of layoffs in the automotive industry. Full Article
Bad weather hurts retail sales
Sales fell at many U.S. apparel retailers and warehouse club stores in June as the weak economy and cool, rainy weather dashed interest in summer shopping for consumers across the country. Full Article
